Clinical trial
Study Of Angiomax In Infants Under Six Months With Thrombosis
NCT00043277 · The Medicines Company, Industry · Completed
Key facts
| NCT number | NCT00043277 |
|---|---|
| Title | Study Of Angiomax In Infants Under Six Months With Thrombosis |
| Official title | Pilot Dose Finding And Efficacy Study Of Angiomax® (Bivalirudin) As Primary Anticoagulation In Infants Under Six Months With Thrombosis |
| Lead sponsor | The Medicines Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Thrombosis |
| Intervention type | Drug |
| Interventions | Angiomax (bivalirudin) |
| Enrollment | 25 |
| Start date | Aug 1, 2002 |
| Completion | Dec 1, 2004 |
| First posted | Aug 8, 2002 |
| Last update posted | Feb 1, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: